Roche OTC Stock Today

RHHBY -  USA Stock  

USD 46.82  0.75  1.63%

Roche Holdings is trading at 46.82 as of the 19th of September 2021; that is 1.63% increase since the beginning of the trading day. The stock's open price was 46.07. Roche Holdings has a very small chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Roche Holdings are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 20th of August 2021 and ending today, the 19th of September 2021. Click here to learn more.
 Market Performance
0 of 100
  Odds Of Distress
Less than 3
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Roche Holdings OTC Stock Profile

Roche Holding AG engages in the prescription pharmaceuticals and diagnostics businesses in Switzerland, Germany, and internationally. The company was founded in 1896 and is headquartered in Basel, Switzerland. Roche Holdings operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. It employs 101465 people. more on Roche Holdings
Roche Holdings generates negative expected return over the last 90 days
Roche Holdings is unlikely to experience financial distress in the next 2 years
Latest headline from ANALYSIS-Chinas biotech sector comes of age with big licensing deals, global ambitions - Reuters
Legal NameRoche Holdings
CEOOsamu Nagayama  (View All)
Average Analyst Recommendation
Analysts covering Roche Holdings report their recommendations after researching Roche Holdings' financial statements, talking to executives and customers, or listening in on Roche Holdings' conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Roche Holdings. The Roche consensus assessment is calculated by taking the average forecast from all of the analysts covering Roche Holdings.
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Roche Holdings' available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Strong SellOvervalued
Roche Holdings [RHHBY] is traded as part of a regulated electronic over-the-counter service offered by the NASD. The company currently falls under 'Mega-Cap' category with current market capitalization of 337.24 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Roche Holdings's market, we take the total number of its shares issued and multiply it by Roche Holdings's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Roche Holdings classifies itself under Healthcare sector and is part of Drug Manufacturers—General industry. The entity has 6.83 B outstanding shares. Roche Holdings has accumulated about 12.34 B in cash with 18.57 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.81.
Check Roche Holdings Probability Of Bankruptcy
Roche Holdings has a total of 6.83 Billion outstanding shares. Roughly 98.0 pct. of Roche Holdings outstanding shares are held by regular investors with 0.0 % owned by insiders and only 1.62 (%) by third-party entities. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.

Ownership Allocation (%)

Check Roche Ownership Details

Roche Stock Price Odds Analysis

What are Roche Holdings' target price odds to finish over the current price? Based on a normal probability distribution, the odds of Roche Holdings jumping above the current price in 90 days from now is about 88.16%. The Roche Holdings probability density function shows the probability of Roche Holdings otc stock to fall within a particular range of prices over 90 days. Assuming the 90 days horizon Roche Holdings has a beta of 0.1712 indicating as returns on the market go up, Roche Holdings average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Roche Holdings will be expected to be much smaller as well. Additionally, the company has a negative alpha, implying that the risk taken by holding this instrument is not justified. Roche Holdings is significantly underperforming DOW.
 Odds Down 46.82HorizonTargetOdds Up 46.82 
11.64%90 days
Based on a normal probability distribution, the odds of Roche Holdings to move above the current price in 90 days from now is about 88.16 (This Roche Holdings probability density function shows the probability of Roche OTC Stock to fall within a particular range of prices over 90 days) .

Roche Stock Institutional Holders

Institutional Holdings refers to the ownership stake in Roche Holdings that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Roche Holdings' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Roche Holdings' value.
InstituionSecurity TypeTotal SharesValue
Ark Investment Management LlcCommon SharesM235.1 M
Fisher Asset Management LlcCommon Shares2.5 M120.1 M
View Roche Holdings Diagnostics

Roche Holdings Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Roche Holdings market risk premium is the additional return an investor will receive from holding Roche Holdings long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Roche Holdings. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Roche Holdings' alpha and beta are two of the key measurements used to evaluate Roche Holdings' performance over the market, the standard measures of volatility play an important role as well.

Roche Stock Against Markets

Picking the right benchmark for Roche Holdings otc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Roche Holdings otc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Roche Holdings is critical whether you are bullish or bearish towards Roche Holdings at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Roche Holdings without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Idea Breakdown Now


Idea Breakdown

Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
All  Next Launch Module

Roche Holdings Corporate Directors

Roche Holdings corporate directors refer to members of a Roche Holdings board of directors. The board of directors generally takes responsibility for the Roche Holdings' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Roche Holdings' board members must vote for the resolution. The Roche Holdings board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Beatrice Mauro - Non-Executive DirectorProfile
DeAnne Julius - Non-Executive DirectorProfile
Claudia Dyckerhoff - Non-Executive DirectorProfile
Julie Brown - Non-Executive DirectorProfile
Additionally, take a look at Your Equity Center. Note that the Roche Holdings information on this page should be used as a complementary analysis to other Roche Holdings' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Fund Screener module to find activelly-traded funds from around the world traded on over 30 global exchanges.

Complementary Tools for Roche OTC Stock analysis

When running Roche Holdings price analysis, check to measure Roche Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Roche Holdings is operating at the current time. Most of Roche Holdings' value examination focuses on studying past and present price action to predict the probability of Roche Holdings' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Roche Holdings' price. Additionally, you may evaluate how the addition of Roche Holdings to your portfolios can decrease your overall portfolio volatility.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
The market value of Roche Holdings is measured differently than its book value, which is the value of Roche that is recorded on the company's balance sheet. Investors also form their own opinion of Roche Holdings' value that differs from its market value or its book value, called intrinsic value, which is Roche Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Roche Holdings' market value can be influenced by many factors that don't directly affect Roche Holdings underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Roche Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine Roche Holdings value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Roche Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.